NCT00651274View on ClinicalTrials.gov

Comparison of Co-administration of Ezetimibe Plus Simvastatin Versus Simvastatin Alone in Primary Hypercholesterolemia (P03476)

PHASE4CompletedINTERVENTIONAL

Enrollment

144

Participants

Timeline

Start Date

April 1, 2003

Primary Completion Date

August 1, 2004

Study Completion Date

August 1, 2004

Conditions

AtherosclerosisHypercholesterolemiaCoronary Heart Disease

Interventions

DRUG

Ezetimibe

oral tablets: ezetimibe 10 mg once daily for 6 weeks (plus continued simvastatin)

DRUG

Placebo

oral tablets: placebo to match ezetimibe 10 mg once daily for 6 weeks (plus continued simvastatin)

All Listed Sponsors

collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

Organon and Co

INDUSTRY

NCT00651274 - Comparison of Co-administration of Ezetimibe Plus Simvastatin Versus Simvastatin Alone in Primary Hypercholesterolemia (P03476) | Biotech Hunter | Biotech Hunter